Eggnog No More: A Case of Cacosmia and Cacogeusia Following COVID-19 Infection

Margarida F. Ferreira, MD^a; David A. Magalhães, MD^b; Rodolfo C. Duarte, MD^c

Prim Care Companion CNS Disord 2022;24(4):22cr03284

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (6)

Vasilieva M, Bejenari I, Groppa S. Differential diagnosis of cacosmia and dysgeusia in COVID-19 pandemic. clinical case report. J Neurol Sci. 2021;429:119781. CrossRef
Izquierdo-Dominguez A, Rojas-Lechuga MJ, Mullol J, et al. Olfactory dysfunction in the COVID-19 outbreak. J Investig Allergol Clin Immunol. 2020;30(5):317–326. PubMed CrossRef
Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA. 2020;323(24):2512–2514. PubMed CrossRef
Ferraro S, Tuccori M, Convertino I, et al. Olfactory and gustatory impairments in COVID-19 patients: role in early diagnosis and interferences by concomitant drugs. Br J Clin Pharmacol. 2021;87(5):2186–2188. PubMed CrossRef
Ismail II, Gad KA. Absent blood oxygen level-dependent functional magnetic resonance imaging activation of the orbitofrontal cortex in a patient with persistent cacosmia and cacogeusia after COVID-19 infection. JAMA Neurol. 2021;78(5):609–610. PubMed CrossRef
Varricchio A, La Mantia I, Brunese FP, et al. Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment. J Biol Regul Homeost Agents. 2021;35(2):683–686. PubMed. CrossRef